
Heat Shock Protein Expression in Skin Keratinocytes of Adults with Atopic Dermatitis
Introduction to Molecular Chaperones in AD
Recent research highlights the significant role of Heat Shock Proteins Atopic Dermatitis in the pathophysiology of skin inflammation. Researchers recently compared the expression of various heat shock proteins (HSP-27, HSP-60, HSP-70, and HSP-90) in the skin keratinocytes of adult patients versus healthy donors. They obtained these keratinocytes by scraping apparently intact skin from the forearm and analyzed them using flow cytometry. The results demonstrate a clear link between these molecular chaperones and the inflammatory state of the skin.
Correlation with Disease Severity
The study found that the expression of HSPs in patients was significantly higher than in healthy controls. Interestingly, this expression level depended directly on the severity of the disease as measured by the SCORAD index. Consequently, clinicians may eventually use these protein levels as objective biomarkers to assess the degree of epidermal stress. During periods of clinical remission, HSP expression levels decreased; however, they rarely returned to baseline control values in most patients. This suggests a persistent state of subclinical cellular stress even when symptoms appear controlled.
The Impact of Heat Shock Proteins Atopic Dermatitis Exacerbation
During acute exacerbations of the condition, researchers observed a significant increase in the levels of phosphorylated HSP forms. This biochemical change reflects heightened stress activity within the keratinocytes. Furthermore, these phosphorylated proteins likely contribute to the cascade of inflammatory signals that drive flares. Because these proteins act as intracellular chaperones, their overexpression indicates that the skin is mounting a protective but ultimately dysfunctional response to chronic inflammation. Understanding these pathways offers a potential foundation for developing targeted therapies that modulate the cellular stress response in chronic dermatological conditions.
Frequently Asked Questions
Do HSP levels normalize during remission in AD patients?
While HSP expression decreases during remission, it usually does not reach the baseline values found in healthy individuals, indicating a lingering state of cellular stress.
How do heat shock proteins relate to the SCORAD index?
There is a significant positive correlation between the expression of HSPs in keratinocytes and the severity of atopic dermatitis as determined by the SCORAD index.
What is the clinical significance of phosphorylated HSP forms?
The presence of phosphorylated HSP forms increases significantly during disease exacerbations, serving as a marker for high stress activity associated with acute inflammation.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
- Elistratova IV et al. Expression of Heat Shock Proteins in Skin Keratinocytes from Adult Patients with Atopic Dermatitis. Bull Exp Biol Med. 2026 Mar 10. doi: 10.1007/s10517-026-06604-1. PMID: 41806342.
- Tukaj S. Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases. Biomolecules. 2022; 12(8):1153.
- Sitko K et al. Heat shock protein 90 inhibition attenuates inflammation in models of atopic dermatitis: a novel mechanism of action. Front Immunol. 2024; 14:1289788.

More from MedShots Daily

A study shows that HSP-27, 60, 70, and 90 levels in skin keratinocytes are significantly higher in atopic dermatitis patients and correlate with disease sev...
2 days back

A review of amylin's physiological benefits, its role in beta-cell cytotoxicity, and the therapeutic potential of amylin analogues in type 2 diabetes....
Today

The Schista study in Zambia highlights a critical association between molecular female genital schistosomiasis (FGS) and oncogenic high-risk HPV genotypes....
Today

A study of 5,834 patients reveals that CKM syndrome is present in 90% of TAVI candidates, significantly impacting procedural success and mortality rates....
Today

China’s drug regulator has approved the world’s first commercial brain-computer interface (BCI) system to restore hand-grasping ability in paralyzed patient...
Today

ACR provides evidence-based recommendations for PNET staging and follow-up, emphasizing CT, MRI, and DOTATATE PET/CT for optimal patient management....
Today